Quadruple therapy for resistant hypertension.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011224:Prazosin / Q000627:therapeutic use
D000959:Antihypertensive Agents; D008750:Methyldopa; D011224:Prazosin; D006145:Guanethidine